• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种与肺腺癌预后不良相关的枢纽基因。

: a hub gene related to poor prognosis for lung adenocarcinoma.

作者信息

Tan Zhibo, Chen Min, Wang Ying, Peng Feng, Zhu Xiaopeng, Li Xin, Zhang Lei, Li Ying, Liu Yajie

机构信息

Department of Radiation Oncology, Peking University Shenzhen Hospital, no. 1120, Lianhua Road, Futian District, Shenzhen, Guangdong Province, 518036, China.

Shenzhen Key Laboratory of Gastrointestinal Cancer Translational Research, Cancer Institute, Shenzhen-Peking University-Hong Kong University of Science & Technology Medical Center, Peking University Shenzhen Hospital, No. 1120, Lianhua Road, Futian District, Shenzhen, Guangdong Province, 518036, China.

出版信息

Biomark Med. 2022 Feb;16(2):83-100. doi: 10.2217/bmm-2021-0919. Epub 2021 Dec 9.

DOI:10.2217/bmm-2021-0919
PMID:34882011
Abstract

The study aims to pinpoint hub genes and investigate their functions in order to gain insightful understandings of lung adenocarcinoma (LUAD). Bioinformatic approaches were adopted to investigate genes in databases including Gene Expression Omnibus, WebGestalt, STRING and Cytoscape, GEPIA2, Oncomine, Human Protein Atlas, TIMER2.0, UALCAN, cBioPortal, TargetScanHuman, OncomiR, ENCORI, Kaplan-Meier plotter, UCSC Xena, European Molecular Biology Laboratory - European Bioinformatics Institute Single Cell Expression Atlas and CancerSEA. Five hub genes were ascertained. was overexpressed in a range of cancers, including LUAD. Promoter methylation, amplification and miRNA regulation might trigger upregulation, signaling poor prognosis. with its coexpressed genes were enriched in the cell cycle pathway. Intratumor heterogeneity of expression could be observed. Cell clusters with expression were more prone to metastasis and epithelial-to-mesenchymal transition. might potentially act as a prognostic biomarker for LUAD.

摘要

该研究旨在确定关键基因并研究其功能,以便深入了解肺腺癌(LUAD)。采用生物信息学方法在包括基因表达综合数据库、WebGestalt、STRING和Cytoscape、GEPIA2、Oncomine、人类蛋白质图谱、TIMER2.0、UALCAN、cBioPortal、TargetScanHuman、OncomiR、ENCORI、Kaplan-Meier绘图仪、UCSC Xena、欧洲分子生物学实验室-欧洲生物信息学研究所单细胞表达图谱和CancerSEA等数据库中研究基因。确定了五个关键基因。在包括肺腺癌在内的一系列癌症中过表达。启动子甲基化、扩增和miRNA调控可能引发上调,预示预后不良。及其共表达基因在细胞周期途径中富集。可观察到表达的肿瘤内异质性。具有表达的细胞簇更容易发生转移和上皮-间质转化。可能潜在地作为肺腺癌的预后生物标志物。

相似文献

1
: a hub gene related to poor prognosis for lung adenocarcinoma.一种与肺腺癌预后不良相关的枢纽基因。
Biomark Med. 2022 Feb;16(2):83-100. doi: 10.2217/bmm-2021-0919. Epub 2021 Dec 9.
2
High Expression of , , and Predicts Worse Prognosis among Nonsmoking Patients with Lung Adenocarcinoma through Bioinformatics Analysis.通过生物信息学分析, 、 、 在不吸烟肺腺癌患者中的高表达预示着更差的预后。
Biomed Res Int. 2020 Oct 20;2020:2071593. doi: 10.1155/2020/2071593. eCollection 2020.
3
Identification of Potential Key Genes and Prognostic Biomarkers of Lung Cancer Based on Bioinformatics.基于生物信息学的肺癌潜在关键基因和预后生物标志物的鉴定。
Biomed Res Int. 2023 Jan 18;2023:2152432. doi: 10.1155/2023/2152432. eCollection 2023.
4
Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma.整合生物信息学分析揭示 CDK1 和 PLK1 是肺腺癌的潜在治疗靶点。
Medicine (Baltimore). 2021 Aug 13;100(32):e26474. doi: 10.1097/MD.0000000000026474.
5
KRT8 and KRT19, associated with EMT, are hypomethylated and overexpressed in lung adenocarcinoma and link to unfavorable prognosis.KRT8 和 KRT19 与 EMT 相关,在肺腺癌中呈低甲基化和过表达,与不良预后相关。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20193468.
6
Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.通过综合生物信息学分析鉴定和验证非小细胞肺癌中具有预后价值的关键基因。
Thorac Cancer. 2020 Apr;11(4):851-866. doi: 10.1111/1759-7714.13298. Epub 2020 Feb 14.
7
Identification of SSBP1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.利用生物信息学方法鉴定 SSBP1 作为人肺腺癌的预后标志物。
Math Biosci Eng. 2022 Jan 18;19(3):3022-3035. doi: 10.3934/mbe.2022139.
8
An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinoma.肺腺癌患者预后和免疫浸润的综合分析,寻找潜在的生存指标的关键基因。
World J Surg Oncol. 2022 Mar 30;20(1):99. doi: 10.1186/s12957-022-02543-z.
9
Chaperonin-containing TCP-1 subunit genes are potential prognostic biomarkers and are correlated with Th2 cell infiltration in lung adenocarcinoma: An observational study.热休克蛋白 10 同源蛋白(TCP-1)复合物亚基基因是潜在的预后生物标志物,并与肺腺癌中 Th2 细胞浸润相关:一项观察性研究。
Medicine (Baltimore). 2024 May 31;103(22):e38387. doi: 10.1097/MD.0000000000038387.
10
Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases.基于 TCGA 和 GEO 数据库的 LUAD 潜在诊断和预后生物标志物的鉴定。
Biosci Rep. 2021 Jun 25;41(6). doi: 10.1042/BSR20204370.

引用本文的文献

1
Multi-Omics and Experimental Validation Reveal Anti-HCC Mechanisms of Tibetan Liuwei Muxiang Pill and Quercetin.多组学与实验验证揭示藏药六味木香丸及槲皮素抗肝癌机制
Pharmaceuticals (Basel). 2025 Jun 16;18(6):900. doi: 10.3390/ph18060900.
2
Predicting breast cancer prognosis based on a novel pathomics model through CHEK1 expression analysis using machine learning algorithms.通过使用机器学习算法进行CHEK1表达分析,基于一种新型病理组学模型预测乳腺癌预后。
PLoS One. 2025 May 9;20(5):e0321717. doi: 10.1371/journal.pone.0321717. eCollection 2025.
3
The mathematical exploration for the mechanism of lung adenocarcinoma formation and progression.
肺腺癌形成和发展机制的数学探索。
Brief Bioinform. 2024 Sep 23;25(6). doi: 10.1093/bib/bbae603.
4
Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation.基于网络药理学、分子对接和实验研究探讨 6-甲氧基二氢血根碱治疗肺腺癌的作用机制。
BMC Complement Med Ther. 2024 May 23;24(1):202. doi: 10.1186/s12906-024-04497-z.
5
A prognostic signature for lung adenocarcinoma by five genes associated with chemotherapy in lung adenocarcinoma.通过与肺腺癌化疗相关的五个基因构建肺腺癌的预后特征。
Clin Respir J. 2023 Dec;17(12):1349-1360. doi: 10.1111/crj.13723. Epub 2023 Dec 10.
6
Identification of Potential Key Genes and Prognostic Biomarkers of Lung Cancer Based on Bioinformatics.基于生物信息学的肺癌潜在关键基因和预后生物标志物的鉴定。
Biomed Res Int. 2023 Jan 18;2023:2152432. doi: 10.1155/2023/2152432. eCollection 2023.